Previous Close | 340.45 |
1-Year Change | -5.53% |
6-Months Change | 1.24% |
3-Months Change | 19.2% |
Moving Avg (50d) | 321.11 |
Moving Avg (200d) | 311.53 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 9.91B |
Beta (3-Years) | 0.96 |
Revenue Growth (ttm) | -3.01% |
Net Profit Margin (ttm) | -5.86% |
Return On Assets (ttm) | -1.34% |
EPS (ttm) | -5.85 |
PE Ratio (ttm) | -58.2 |
Dividend Yield | % |
Asset Description: | Bio-Rad Laboratories, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-06-24 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
347.259 | 357.473 | 364.282 | 374.495 | 391.518 | 408.54 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.